None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Male patient who visited urology department with overactive bladder according to ICS criteria or male patients who visited urology department due to lower urinary tract symptoms and patients with overactive bladder according to ICS criteria despite of a-blocker treatment ? Patients with an OABSS total score = 3 and No. 3 (urgent urine) = 2 score ? Those who have voluntarily agreed in writing to participate in this study
Exclusion criteria
Exclusion criteria: ? Patient whose bacterium is cultured by urinalysis ? Patients with urethral or bladder neck stenosis ? Patients with urinary stones ? cancer in urinary tract ? Patients with urethral diverticulum ? Patients with Tuberculosis ? Patients with a history of pelvic radiation therapy ? Those who can not follow up until 3 months after treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean OABSS score before and after treatment in both groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference between the two groups in terms of mean IPSS scores;Difference between the two groups in terms of mean IPSS subscores(storage symptoms, voiding symptoms, and QOL(quality of life));Difference between the two groups in terms of mean OABSS subscores (Urgency, Daytime Frequency, Night-Time Frequency, and Urgency Incontinence);safety evaluation: side effects, laboratory test results | — |
Countries
Korea, Republic of
Contacts
Koera University Guro Hospital